HomePROGEN • STO
add
Prostatype Genomics AB
Previous close
kr 9.00
Day range
kr 9.00 - kr 9.35
Year range
kr 6.30 - kr 120.00
Market cap
47.88M SEK
Avg Volume
30.93K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 724.00K | 8.17% |
Operating expense | 5.02M | -29.79% |
Net income | -9.83M | 22.87% |
Net profit margin | -1.36K | 28.70% |
Earnings per share | — | — |
EBITDA | -9.70M | 20.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.78M | -84.74% |
Total assets | 32.27M | -7.16% |
Total liabilities | 18.99M | 225.94% |
Total equity | 13.29M | — |
Shares outstanding | 990.81K | — |
Price to book | 0.67 | — |
Return on assets | -75.15% | — |
Return on capital | -182.53% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -9.83M | 22.87% |
Cash from operations | -11.61M | -15.45% |
Cash from investing | -3.27M | -345.65% |
Cash from financing | 14.40M | -30.00% |
Net change in cash | -448.50K | -104.58% |
Free cash flow | -9.58M | -9.77% |
About
Founded
2007
Website
Employees
6
